TesamorelinSecretagogue PeptideSafety Rating 8/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Save ~98% vs Manufacturer direct
Research-grade Tesamorelin is for laboratory and research use only, not approved for human consumption. Always consult a licensed physician before working with any compound. FDA-approved 2010 for HIV-associated lipodystrophy. Specialty pricing means retail and cash-pay are essentially identical. Off-label use for VAT reduction is what drives research-vendor demand.
See all Tesamorelin vendors →Price Comparison
Compare vendors · per 10mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Puratek PeptidesBest $/mgCOA ✓ · 3P | $94.45 | $4.72 | May 19, 2026 | Buy → |
| Puratek PeptidesCOA ✓ · 3P | $49.46 | $4.95 | May 19, 2026 | Buy → |
| Amino ClubCOA ✓ · 3P | $155.38 | $5.18 | May 14, 2026 | Buy → |
| Red River PeptidesCOA ✓ · 3PAvailable on backorder | $55.25 | $5.52 | May 19, 2026 | Buy → |
| SomaChemsCOA ✓ · 3P | $59.99 | $6.00 | May 14, 2026 | Buy → |
Overview
About Tesamorelin
Mechanism of action
Stabilized GHRH analogue; stimulates pulsatile GH release; reduces visceral adipose tissue (VAT) via IGF-1 mediated lipolysis. FDA-approved for HIV-associated lipodystrophy.
Safety profile
Water retention, joint pain, insulin resistance, peripheral edema, injection site reactions, glucose elevation. · Approved for HIV lipodystrophy; injection site reactions; fluid retention; well-characterized
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Tesamorelin below your target.
Safety & Interactions
Contraindications & Drug Interactions
Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.
Active malignancy.
Pituitary disease (hypopituitarism, pituitary tumor, etc.).
Pregnancy — embryofetal toxicity.
Related pages
More on Tesamorelin
Stack & Compare
Frequently Researched Together
Learn More
Tesamorelin Guide
The FDA-approved GHRH analog used in body composition research.
Read full guide · 8 min read →Research
Studies & key findings
- FDA-approved (Egrifta) for HIV-associated lipodystrophy — reduces visceral adipose tissue by 15–18% in pooled Phase 3 analyses, with Study 1 showing 15.2% VAT reduction vs a 5% increase in placebo at 26 weeks.
- Reduces liver fat and improves hepatic transcriptomics in HIV-associated NAFLD, suggesting benefit beyond cosmetic fat redistribution.